MYB and CD4+/CD56+ hematodermic neoplasm: Rearrangements of the hematopoietic transcription factor MYB are recurrently found in 20% of patients with blastic plasmacytoid DC neoplasm (BPDCN), a rare leukemia arising from cells of the plasmacytoid DC (pDC) lineage (1–4).